Solventum Co. (NYSE:SOLV) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its position in Solventum Co. (NYSE:SOLV) by 6.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 214,838 shares of the company’s stock after selling 14,229 shares during the period. California Public Employees Retirement System’s holdings in Solventum were worth $14,192,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SOLV. Worldquant Millennium Advisors LLC grew its position in shares of Solventum by 373.6% in the third quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company’s stock valued at $3,323,000 after purchasing an additional 37,600 shares during the last quarter. Harbor Capital Advisors Inc. increased its position in Solventum by 24.8% during the fourth quarter. Harbor Capital Advisors Inc. now owns 46,965 shares of the company’s stock worth $3,103,000 after buying an additional 9,333 shares in the last quarter. State Street Corp raised its holdings in shares of Solventum by 3.1% in the third quarter. State Street Corp now owns 6,107,550 shares of the company’s stock worth $425,818,000 after acquiring an additional 185,938 shares during the last quarter. Forsta AP Fonden purchased a new stake in shares of Solventum in the fourth quarter valued at $1,876,000. Finally, New York State Teachers Retirement System lifted its position in shares of Solventum by 4.0% in the fourth quarter. New York State Teachers Retirement System now owns 124,699 shares of the company’s stock valued at $8,238,000 after acquiring an additional 4,819 shares in the last quarter.

Solventum Price Performance

Shares of Solventum stock opened at $66.22 on Friday. The stock has a market capitalization of $11.45 billion and a P/E ratio of 24.08. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The business’s fifty day moving average price is $75.42 and its 200 day moving average price is $71.95. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $85.92.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on SOLV. Bank of America boosted their target price on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. Mizuho boosted their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Wells Fargo & Company raised their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. The Goldman Sachs Group boosted their price target on Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday, March 3rd. Finally, Morgan Stanley raised their price objective on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Solventum has an average rating of “Hold” and a consensus price target of $79.86.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.